Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.
Pharmacoeconomics
; 42(8): 829-832, 2024 Aug.
Article
in En
| MEDLINE
| ID: mdl-38717708
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Technology Assessment, Biomedical
/
Cost-Benefit Analysis
/
Diabetes Mellitus, Type 2
/
Hypoglycemic Agents
Limits:
Humans
Language:
En
Journal:
Pharmacoeconomics
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2024
Document type:
Article
Affiliation country:
Netherlands